EIT Health
Transformative Healthcare Instrument
Last updated:
The Transformative Healthcare Instrument funds European SMEs to develop biotech, medtech, digital health, and diagnostic innovations addressing unmet clinical needs, with grants of €300,000-€500,000 covering up to 50% of total project costs. Eligible SMEs must have at least 4 FTE employees and €2 million in equity investment closed in the prior 36 months; applicants must secure 50% co-funding. This is a single-stage, non-consortium call from EIT Health with a deadline of 16 September 2026.
Details
| Funder | EIT Health |
| Budget | €300k–€500k |
| Deadline | 16 September 2026 |
| Consortium | No - individual applicant company; single SME applicant, no partner organisation required |
| Application | Single stage |
| TRL | 5-7 |
| Frequency | Annual |
Eligibility & scope
Funding for private SMEs (min. 4 FTE) in biotech, medtech, digital health, AI, biomarkers or diagnostics that have closed at least €2M equity investment within the previous 36 months. Requires minimum Innovation Maturity Level depending on sector (IML 5-7); EIT Health funds max 50% of costs, remainder must be co-funded by the company.
Who Should Apply
- •European SMEs with ≥4 FTE employees and ≥€2M equity investment closed in prior 36 months
- •Biotech projects at IML≥5 technology readiness
- •Medtech innovations at IML≥6 readiness or higher
- •Digital health and AI solutions at IML≥7 readiness
- •Biomarker and diagnostic tools at IML≥7 readiness
Key Dates
- •Application deadline: 16 September 2026
- •Application platform opens: 15 July 2026
- •Single-stage evaluation
Tips for Applicants
- ✓EIT Health requires matching co-funding of 50% of total project costs; secure committed funding partners before submission.
- ✓Technology maturity is gated by scope: medtech and biomarkers must be at IML≥6-7; earlier-stage projects should route to different EIT Health calls.
- ✓Align your unmet clinical need narrative to a clear European patient or healthcare system pain point; EIT Health panels prioritise clinical impact over technical novelty alone.
Frequently Asked Questions
How much can I receive from the EIT Health Transformative Healthcare Instrument?
Up to €500,000, covering a maximum of 50% of your total project costs; you must secure 50% co-funding from your own resources or partners.
Who is eligible for this EIT Health call?
European SMEs with at least 4 FTE employees and at least €2 million in equity investment closed within the 36 months prior to the deadline.
What technology maturity level do I need?
Biotech projects require IML≥5; medtech requires IML≥6; digital health, AI, biomarkers, and diagnostics require IML≥7.
Is co-funding required for the Transformative Healthcare Instrument?
Yes, you must secure 50% co-funding; EIT Health covers the other 50% up to the stated maximum.
Can multi-country consortiums apply?
No, this is a single-applicant (non-consortium) call; the SME must be European and meet the FTE and equity criteria alone.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
Similar grants
Innovation Uptake
EIT HealthDeadline: 16 Sept 2026Up to €650,000 per project (total call budget €5.2M, up to 8 projects; SMEs leading projects receive €400,000–€500,000)Bootcamps Providers
EIT HealthDeadline: 2 Nov 2026Up to €610,000 total; up to €112,000 for Foundational Learning Path, up to €124,500 per Thematic Learning Path (max 4 thematic projects)SME Call
Health~HollandDeadline: 20 Nov 2026€225k–€450kBiotech Innovation Path Call
EIT HealthDeadline: 16 Sept 2026Up to €240,000 per projectPPP SME Call – Labour-Saving Technology Track
Health~HollandDeadline: 20 Nov 2026€225k–€450k
Browse Related
Could Transformative Healthcare Instrument be right for you?
Deadline in 3 days. See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →